PrEP Biopharm

News & Events

Press Releases

On: May 20, 2018
Safety and efficacy of PrEP-001, a novel immunomodulator, for prevention of viral respiratory infection in subjects with asthma

On: May 20, 2018

Safety and nasal cytokine response of PrEP-001, a novel immunomodulatory nasal spray for prophylaxis of respiratory viral infections

on March 19, 2018

Publication: PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials

London, United Kingdom, August 11, 2016

PrEP Biopharm Limited announces addition of Jim Cornelius and Clive Page to its Board of Directors

Nov. 2, 2015

PrEP Biopharm Limited Closes GBP 21 Million Series A Financing